Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: September 3, 2002
Last updated: May 20, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2002
  Primary Completion Date: September 2002 (Final data collection date for primary outcome measure)